مصطلحات الفهرس: computer assisted tomography, controlled study, diagnosis, endocrine surgery, endoscopic ultrasonography, female, human, insulinoma, medical record, middle aged, preoperative evaluation, retrospective study, scintiscanning, calcium, endogenous compound, glucagon like peptide 1 receptor, adult, provocation test, article, clinical article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handleTest/1/28724
Click here for full text options
LibKey Link

مصطلحات الفهرس: computer assisted tomography, controlled study, diagnosis, endocrine surgery, endoscopic ultrasonography, female, human, insulinoma, medical record, middle aged, preoperative evaluation, retrospective study, scintiscanning, calcium, endogenous compound, glucagon like peptide 1 receptor, adult, provocation test, article, clinical article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handleTest/1/28724
ANZ Journal of Surgery
LibKey Link

مصطلحات الفهرس: dapagliflozin, empagliflozin, ertugliflozin, glucagon like peptide 1 receptor agonist/ae [Adverse Drug Reaction], hemoglobin A1c/ec [Endogenous Compound], liraglutide, metformin, sodium glucose cotransporter 2 inhibitor, risk factor, cardiovascular mortality, gastrointestinal symptom/si [Side Effect], glucose blood level, glycemic control, heart infarction, human, hypoglycemia, non insulin dependent diabetes mellitus, patient care, quality of life, review, canagliflozin, Review

URL: Medicine Today
Click here for full text options
LibKey Link

مصطلحات الفهرس: dapagliflozin, empagliflozin, ertugliflozin, glucagon like peptide 1 receptor agonist/ae [Adverse Drug Reaction], hemoglobin A1c/ec [Endogenous Compound], liraglutide, metformin, sodium glucose cotransporter 2 inhibitor, risk factor, cardiovascular mortality, gastrointestinal symptom/si [Side Effect], glucose blood level, glycemic control, heart infarction, human, hypoglycemia, non insulin dependent diabetes mellitus, patient care, quality of life, review, canagliflozin, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handleTest/1/35999
Medicine Today
LibKey Link

مصطلحات الفهرس: patient care, practice guideline, review, angiotensin receptor antagonist/dt [Drug Therapy], antilipemic agent, calcium channel blocking agent/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], dipeptidyl peptidase IV inhibitor/cb [Drug Combination], dipeptidyl peptidase IV inhibitor/dt [Drug Therapy], ezetimibe/dt [Drug Therapy], glucagon like peptide 1 receptor agonist/dt [Drug Therapy], hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], insulin/dt [Drug Therapy], metformin/cb [Drug Combination], metformin/dt [Drug Therapy], nicotinic acid/dt [Drug Therapy], sodium glucose cotransporter 2 inhibitor/cb [Drug Combination], sodium glucose cotransporter 2 inhibitor/dt [Drug Therapy], sulfonylurea/cb [Drug Combination], sulfonylurea/dt [Drug Therapy], thiazide diuretic agent/dt [Drug Therapy], bile acid sequestrant/dt [Drug Therapy], add on therapy, cardiovascular disease/co [Complication], cardiovascular risk, clinical outcome, early diagnosis, female, high risk patient, human, hyperlipidemia/dt [Drug Therapy], hypertension/dt [Drug Therapy], non insulin dependent diabetes mellitus/di [Diagnosis], non insulin dependent diabetes mellitus/dt [Drug Therapy], non insulin dependent diabetes mellitus/pc [Prevention], non insulin dependent diabetes mellitus/th [Therapy], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handleTest/1/41520
Medicine Today
Click here for full text options
LibKey Link

مصطلحات الفهرس: patient care, practice guideline, review, angiotensin receptor antagonist/dt [Drug Therapy], antilipemic agent, calcium channel blocking agent/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], dipeptidyl peptidase IV inhibitor/cb [Drug Combination], dipeptidyl peptidase IV inhibitor/dt [Drug Therapy], ezetimibe/dt [Drug Therapy], glucagon like peptide 1 receptor agonist/dt [Drug Therapy], hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], insulin/dt [Drug Therapy], metformin/cb [Drug Combination], metformin/dt [Drug Therapy], nicotinic acid/dt [Drug Therapy], sodium glucose cotransporter 2 inhibitor/cb [Drug Combination], sodium glucose cotransporter 2 inhibitor/dt [Drug Therapy], sulfonylurea/cb [Drug Combination], sulfonylurea/dt [Drug Therapy], thiazide diuretic agent/dt [Drug Therapy], bile acid sequestrant/dt [Drug Therapy], add on therapy, cardiovascular disease/co [Complication], cardiovascular risk, clinical outcome, early diagnosis, female, high risk patient, human, hyperlipidemia/dt [Drug Therapy], hypertension/dt [Drug Therapy], non insulin dependent diabetes mellitus/di [Diagnosis], non insulin dependent diabetes mellitus/dt [Drug Therapy], non insulin dependent diabetes mellitus/pc [Prevention], non insulin dependent diabetes mellitus/th [Therapy], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handleTest/1/41520
Medicine Today
Click here for full text options
LibKey Link